Continuation rate for asenapine and brexpiprazole treatment in elderly patients with schizophrenia

Saved in:
Bibliographic Details
Published inPsychogeriatrics Vol. 21; no. 6; pp. 950 - 951
Main Authors Suzuki, Hidenobu, Hibino, Hiroyuki, Inoue, Yuichi, Takaya, Atsuhiko, Mikami, Katsunaka, Yamamoto, Kenji, Matsumoto, Hideo
Format Journal Article
LanguageEnglish
Published Melbourne John Wiley & Sons Australia, Ltd 01.11.2021
Blackwell Publishing Ltd
Subjects
Aged
Antipsychotic Agents - adverse effects
Dibenzocycloheptenes
Humans
Mental disorders
Quinolones - therapeutic use
Schizophrenia
Schizophrenia - drug therapy
Thiophenes
Online AccessGet full text

Cover

More Information
Bibliography:Disclosure: Dr. Suzuki has received honoraria from Janssen Pharmaceutical K.K, Otsuka Pharmaceutical Co., Ltd., Meiji Seika Pharma Co., Ltd., and Eisai Co., Ltd. Dr. Hibino has received honoraria from Janssen Pharmaceutical K.K, Otsuka Pharmaceutical Co., Ltd., and Dainippon Sumitomo Pharma Co., Ltd. Dr. Inoue has received honoraria from Janssen Pharmaceutical K.K and Otsuka Pharmaceutical Co., Ltd. Dr. Mikami received: a) research supports from Grant‐in Aid for Scientific Research (C) (Grant Number 18K07611), Otsuka Pharmaceutical, Shionogi & Co., Japanese Society for Probiotic Science; b) honoraria from Otsuka Pharmaceutical, Shionogi & Co., Shire Japan, Meiji Holdings Co., Takeda Pharmaceutical, Miyarisan Phamaceutical Co; and c) a consulting fee from Otsuka Pharmaceutical, Shionogi & Co, and Viatris. Dr. Yamamoto reports grants from Esai Co., Ltd., grants and personal fees from Otsuka Pharmaceutical Co., Ltd., personal fees from Meiji Seika Pharma Co., Ltd., personal fees from Sumitomo Dainippon Pharma Co., Ltd., personal fees from Pfizer Japan Inc., personal fees from Mitsubishi Tanabe Pharma Corporation, personal fees from TEIJIN Pharma Limited, personal fees from Eli Lilly and Company, personal fees from Yoshitomiyakuhin Corporation, personal fees from Janssen Pharmaceutical K.K., personal fees from Merck Sharp & Dohme, personal fees from GlaxoSmithKline K.K., personal fees from EPS Holdings, Inc., grants from Health and Labor Sciences Research Grant, outside the submitted work. Dr. Matsumoto received: a) research support from Shionogi & Co., Ltd.; b) honoraria from Pfizer Inc.; Otsuka Pharmaceutical Co., Ltd.; Janssen Pharmaceutical K.K.; Shionogi & Co., Ltd.
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1346-3500
1479-8301
DOI:10.1111/psyg.12760